

Cover Story
PodcastThe Directors
By Sara Willa Ernst and Paul Goldberg
Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019).
Cancer Policy


In Brief


Clinical Roundup
Drugs & Targets



CURRENT ISSUE



CURRENT ISSUE
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants
- Michael Bishop, Nobel-winning cancer researcher, dies at 90
- Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?” - At a jam-packed NCAB meeting, cancer vaccines and site visits take center stage
- CBER Director Vinay Prasad dared to “say no to drugs”















